Loading...
XNASGCTK
Market cap4mUSD
Dec 24, Last price  
0.26USD
1D
-8.72%
1Q
-89.06%
IPO
-99.67%
Name

GlucoTrack Inc

Chart & Performance

D1W1MN
XNAS:GCTK chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
45.08%
Rev. gr., 5y
8.45%
Revenues
0k
0000059,775143,167611,689589,46243,488208,7620000
Net income
-7m
L+59.91%
-1,202,296-2,788,446-2,364,339-2,772,307-9,796,8532,980,426-5,842,172-5,409,737-10,328,806-6,715,420-3,516,189-2,598,000-4,100,000-4,438,000-7,097,000
CFO
-7m
L+75.86%
-1,367,837-1,916,113-2,296,989-3,217,767-3,361,645-4,565,224-5,311,830-5,895,119-4,892,277-3,899,087-3,501,000-3,769,000-3,729,000-6,558,000

Profile

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
URL
http://www.integrity-app.com/
IPO date
Apr 09, 2013
Employees
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
Cost of revenue
7,117
4,444
3,972
Unusual Expense (Income)
NOPBT
(7,117)
(4,444)
(3,972)
NOPBT Margin
Operating Taxes
3
33
Tax Rate
NOPAT
(7,117)
(4,447)
(4,005)
Net income
(7,097)
59.91%
(4,438)
8.24%
(4,100)
57.81%
Dividends
Dividend yield
Proceeds from repurchase of equity
8,730
BB yield
-804.04%
Debt
Debt current
23
Long-term debt
196
195
267
Deferred revenue
Other long-term liabilities
Net debt
(4,296)
(2,132)
(5,823)
Cash flow
Cash from operating activities
(6,558)
(3,729)
(3,769)
CAPEX
(1,000)
(5)
Cash from investing activities
1,000
(1,000)
Cash from financing activities
8,730
FCF
(7,104)
(4,378)
(3,799)
Balance
Cash
4,492
2,312
6,062
Long term investments
15
51
Excess cash
4,492
2,327
6,113
Stockholders' equity
(109,769)
(101,869)
(97,457)
Invested Capital
113,162
103,294
102,862
ROIC
ROCE
EV
Common stock shares outstanding
4,152
15,475
15,451
Price
0.26
-81.45%
1.41
-66.19%
4.17
-9.64%
Market cap
1,086
-95.02%
21,819
-66.13%
64,430
-7.42%
EV
(3,210)
19,687
58,607
EBITDA
(7,104)
(4,421)
(3,930)
EV/EBITDA
0.45
Interest
3
Interest/NOPBT